Composition
- Active ingredients
- TRAVOPROST 0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA204822.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Izba
- Active substance
- travoprost
- Drug class
- Prostaglandin analogues
- Route
- Eye
- Dosage form
- Solution/drops
- Applicant
- Novartis
- Status
- Discontinued
- FDA approval
- 15 May 2014
- Application
- NDA204822-001
- RxCUI
- 283809